![](https://investorshub.advfn.com/uicon/19649.png?cb=1607617291)
Sunday, September 06, 2020 1:22:41 PM
---
Relief Therapeutics share: Will this be the next price explosion?
By Christina Rothstein -6 September 2020
Just a few weeks ago, most investors had very little to do with Relief Therapeutics. However, the Swiss company made a name for itself overnight with the hopeful Aviptadil, which is considered extremely promising in the treatment of Corona patients. The prices have exploded and are still at a very high level, despite the interim correction. The latest reports offer hope that the prices could soon target higher spheres again. On Friday, we were already heading in the right direction.
Should investors sell immediately? Or is it worth getting started at Relief Therapeutics?
Support for research
As Relief Therapeutics announced over the weekend, the company is now receiving support in the form of a new CEO. Gilles Della Corte joins the company, which has 30 years of experience in the biopharmaceutical industry alone. Among other things, he will be responsible for the clinical development of Aviptadil in Europe and will work with NeuroRx to work towards approval both in local areas and in the USA. /// This gives the impression that research and development is now being properly pressed on the gas. ///
Relief Therapeutics shares soar
On the stock exchange, the news was well received. Buyers sent Relief Therapeutics shares up more than 3 percent on Friday, successfully defending the 0.50 CHF mark at the close of the week. The paper takes further upside potential into the new week. The long-term outcome will depend to a large extent on the further development around Aviptadil. Speed is a factor that should not be underestimated. After all, the expected sales are all the higher as long as no approved vaccine is available and the number of infections continues to increase worldwide.
Buy, Hold or Sell – Your Relief Therapeutics Analysis of 06.09. provides the answer:
How will Relief Therapeutics develop now? Is your money safe in this stock? The answers to these questions and why you need to act now can be found in the latest Relief Therapeutics Stock analysis.
Relief Therapeutics: Buy or sell? (read more here)
https://www.finanztrends.info/relief-therapeutics-aktie-bringt-das-die-naechste-kursexplosion/
~ Money Making Money ~
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM